Dianthus Therapeutics
The Director/Senior Director, Program Management is responsible for managing and tracking interdisciplinary drug development programs, collaborating closely with scientific leadership and cross‑functional teams to develop and execute program strategy, operations, and budgets. The role ensures alignment with corporate goals, mitigates risks, and drives effective communication and decision‑making across internal and external partners.
Dianthus Therapeutics is a biotechnology company focused on developing next‑generation antibody therapeutics that target the complement system to address diseases with high unmet medical need. The company engineers selective, potent complement‑modulating antibodies with the goal of improving safety and efficacy over existing therapies. Dianthus advances novel antibody candidates toward clinical development and is committed to translating complement biology into meaningful treatments for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dianthus Therapeutics.
Dianthus Therapeutics didn’t post a salary, so this is our estimate from similar listings.
15% below the average for this role
Truist Financial Forecasts Strong Price Appreciation for Dianthus Therapeutics (NASDAQ:DNTH) Stock
2 hours ago